-10.90 (-0.92%) Dr. Reddy's Laboratories has reported results for third quarter ended December 31, 2022 (Q3FY23).
The company has reported a fall of 4.84% in its net profit at Rs 324.60 crore for the quarter under review as compared to Rs 341.10 crore for the same quarter in the previous year. However, total income of the company increased 11.47% at Rs 3949.00 crore for Q3FY23 as compared to Rs 3542.60 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported rise of 75.37% in its net profit at Rs 1243.90 crore for the quarter under review as compared to Rs 709.30 crore for the same quarter in the previous year. Total income of the company increased 26.96% at Rs 6848.50 crore for Q3FY23 as compared to Rs 5394.10 crore for the corresponding quarter previous year.